Corient Private Wealth LLC Raises Stock Holdings in iShares Biotechnology ETF $IBB

Corient Private Wealth LLC boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 113.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 62,227 shares of the financial services provider’s stock after acquiring an additional 33,099 shares during the quarter. Corient Private Wealth LLC’s holdings in iShares Biotechnology ETF were worth $10,503,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter worth approximately $201,000. AQR Capital Management LLC bought a new position in iShares Biotechnology ETF in the 1st quarter worth $455,000. Millennium Management LLC lifted its position in shares of iShares Biotechnology ETF by 140.8% in the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares during the period. M&T Bank Corp boosted its stake in shares of iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock valued at $337,000 after purchasing an additional 750 shares in the last quarter. Finally, Walleye Capital LLC increased its position in shares of iShares Biotechnology ETF by 26.8% during the second quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock valued at $589,000 after buying an additional 985 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $181.53 on Thursday. The company has a 50-day simple moving average of $171.07 and a two-hundred day simple moving average of $170.83. iShares Biotechnology ETF has a one year low of $125.70 and a one year high of $183.04.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a $0.0238 dividend. This represents a $0.10 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.